Cite
MLA Citation
P Rutgeerts et al.. “OC-005 A Multicenter, Double-Blind, Placebo (PBO)-Controlled Ph3 Study of Ustekinumab (UST), A Human IL-12/23P40 MAB, in Moderate-Severe Crohn's Disease (CD) Refractory to anti-TNFΑ: UNITI-1.” Gut, vol. 65, n.d., pp. A3–A4. http://access.bl.uk/ark:/81055/vdc_100137790519.0x00004d